Selecting effective antisense reagents on combinatorial oligonucleotide arrays View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1997-06

AUTHORS

Natalie Milner, Kalim U. Mir, Edwin M. Southern

ABSTRACT

An array of 1,938 oligodeoxynucleotides (ONs) ranging in length from monomers to 17-mers was fabricated on the surface of a glass plate and used to measure the potential of oligonucleotide for heteroduplex formation with rabbit β-globin mRNA. The oligonucleotides were complementary to the first 122 bases of mRNA comprising the 5′ UTR and bases 1 to 69 of the first exon. Surprisingly few oligonucleotides gave significant heteroduplex yield. Antisense activity, measured in a RNase H assay and by in vitro translation, correlated well with yield of heteroduplex on the array. These results help to explain the variable success that is commonly experienced in the choice of antisense oligonucleotides. For the optimal ON, the concentration required to inhibit translation by 50% was found to be five times less than for any other ON. We find no obvious features in the mRNA sequence or the predicted secondary structure that can explain the variation in heteroduplex yield. However, the arrays provide a simple empirical method of selecting effective antisense oligonucleotides for any RNA target of known sequence. More... »

PAGES

537-541

Journal

TITLE

Nature Biotechnology

ISSUE

6

VOLUME

15

Related Patents

  • Trpm-2 Antisense Therapy
  • Permits Multiplex Detection Of Nucleic Acid Sequence Differences; Ldr Coupled To Pcr; Primary Pcr Coupled To Secondary Pcr Coupled To Ldr; And Primary Pcr Coupled To Secondary Pcr; Each Have Particular Applicability In Detecting Certain Characteristics
  • Hybrid Nucleic Acids; Prevent, Controlling Gene Expression; Antiinflammatory Agents
  • A 21-Base Antisense Oligonucleotide Which Inhibits Gene Expression Of Testosterone-Repressed Prostate Message-2 By Tumor Cells; Prostate And Renal Cell Cancer; Enhanced Chemosensitivity, Hormone And Radiation Sensitivities
  • Detection Of Nucleic Acid Sequence Differences Using Coupled Ligase Detection With Padlock Probes And Polymerase Chain Reactions
  • Detection Of Nucleic Acid Sequence Differences Using Coupled Ligase Detection And Polymerase Chain Reactions
  • Clusterin Antisense Therapy For Treatment Of Cancer
  • Detecting Preferential Exons Within Genomes; Obtain Sample, Incubate With Probes, Detect Hybridization In Genome, Map Binding Profile
  • Anticarcinogenic Agent Is Conjugated With A Nucleic Acids, For Cancer Treatment; A Kit For Detection; Chemical Intermediates
  • Antisense Modulation Of Ptp1b Expression
  • Antisense Inhibition Of Ptp1b Expression
  • Modulation Of Cd40 Expression
  • Antisense Modulation Of Protein Phosphatase 2 Catalytic Subunit Beta Expression
  • Antisense Oligonucleotides Directed Against Connective Tissue Growth Factor And Uses Thereof
  • Method Of Treating Keloids Or Hypertrophic Scars Using Antisense Compounds Targeting Connective Tissue Growth Factor (Ctgf)
  • Antisense Oligonucleotide Modulation Of Stat3 Expression
  • Very Short Bcl-2 Antisense Oligonucleotides Ranging From 7-9 Bases In Lipid Formulations; Induce Growth Inhibition In Human Leukemic Cells; Combined With Uncharged Lipid And A Carrier; Anticarcinogenic Agents; Tissue-Targeted Therapy; Nucleic Sequences
  • Target-Dependent Reactions Using Structure-Bridging Oligonucleotides
  • Modulation Of Signal Transducer And Activator Of Transcription 3 (Stat3)Expression
  • Modulation Of The Expression Of The Pka Regulatory Rii Subunit Alpha May Provide A Means Of Regulating The Expression Of Pka; Modulation Of Its Activity Is A Potential Strategy With Which To Treat Metabolic Or Developmental Disorders
  • Forming A Ligation Product On A Target Nucleotide Sequence; Amplifying The Product; Detecting The Amplified Product, And Identifying The Target Nucleotide Sequence; Multiplex Methods
  • Device For Identifying Sequences In Multiplex Analysis To Identify Genetic Disorders, In Forensics Or Food Safety Use; Support Functionalized With Silanes And/Or Ethenically Unsaturated Monomers For Repeatedly Hybridizing Oligonucleotides To Capture Probes
  • Target-Dependent Reactions Using Structure-Bridging Oligonucleotides
  • Rna Interference Mediated Inhibition Of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (Sina)
  • Antisense Modulation Of Sr-Cyp Expression
  • Antisense Inhibition Of Cyclin D2 Expression
  • Treatment Of Cancer By Inhibition Of Igfbps And Clusterin
  • Folate Derived Conjugates Of Double Stranded Nucleic Acids, Used For The Delivery Of Drugs To Specific Cell Types
  • Antisense Modulation Of Pka Regulatory Subunit Rii Alpha Expression
  • Antisense Modulation Of Dual Specific Phosphatase 5 Expression
  • Detection Of Nucleic Acid Sequence Differences Using The Ligase Detection Reaction With Addressable Arrays
  • Antisense Modulation Of Pecam-1
  • Determination Of Structure Formation In Nucleic Acid Targets; Obtain Folded Target Nucleotide Sequences, Incubate With Oligonucleotide Probes, Monitor Conformation Of Hybridized Structures
  • Antisense Modulation Of Src-1 Expression
  • Compositions And Methods Of Targeting Apolipoprotein B For The Reduction Of Apolipoprotein C-Iii
  • Rna Interference Mediated Inhibition Of Gene Expression Using Short Interfering Nucleic Acids (Sina)
  • Detection Of Nucleic Acid Sequence Differences Using Coupled Ligase Detection And Polymerase Chain Reactions
  • Antisense Modulation Of Syntaxin 4 Interacting Protein Expression
  • Rna Interference Mediated Inhibition Of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (Sina)
  • Trpm-2 Antisense Therapy Using An Oligonucleotide Having 2′-O-(2-Methoxy)Ethyl Modifications
  • Detection Of Preferential Nucleotide Sequences On Solid Support; Generate Solid Support, Incubate With Nucleotide Sequences, Expose To Probe, Detect Signal, Presence Of Signal Indicates Preferential Nucleotide Sequences
  • Hiv Infection Inhibitors
  • A Therapy Method For Cellular Senescence Or Increased Proliferation By Administering A Therapeutic Agent To Cells That Reduces Loss Of Telomere Repeats During Proliferation
  • Modified Protein Kinase A-Specific Oligonucleotides And Methods Of Their Use
  • Antisense Modulation Of Protein Kinase C-Theta Expression
  • Chemically Modified Multifunctional Short Interfering Nucleic Acid Molecules That Mediate Rna Interference
  • Methods For Slowing Familial Als Disease Progression
  • Methods For Placing, Accepting, And Filling Orders For Products And Services
  • Antisense Inhibition Of Map Kinase Kinase 6 Expression
  • Detection Of Nucleic Acid Sequence Differences Using Coupled Ligase Detection And Polymerase Chain Reactions
  • Compositions And Methods For Treating Pancreatic Cancer
  • Methods Of Inhibiting Cancer Cells With Adnf Iii Antisense Oligonucleotides
  • Estrogen Receptor Site-Specific Ribozymes And Uses Thereof For Estrogen Dependent Tumors
  • Antisense Modulation Of Superoxide Dismutase 1, Soluble Expression
  • Modulation Of Cd40 Expression
  • Antisense Oligonucleotide Modulation Of Mdr P-Glycoprotein Gene Expression
  • Antisense Oligonucleotides Against Tenascin For Treating Vitiligo
  • Anticarcinogenic/Antitumor/Antiproliferative Agents And Diagnostic Agents Targeted Against Gene Which Codes For A Protein Kinase Involved In Signal Transduction
  • Antisense Inhibition Of Rad51
  • Preparing Oligonucleotide Sequences; Providing An Apparatus Which Contains Stored Oligonucleotides, Heat The Apparatus, Polymerize The Nucleotide Sequences, Release And Recover The Nucleotide Sequences
  • For Therapy Of Hiv Infection
  • Detection Of Nucleic Acid Sequence Differences Using Coupled Polymerase Chain Reactions
  • Detection Of Nucleic Acid Sequence Differences Using The Ligase Detection Reaction With Addressable Arrays
  • Method For Identifying Accessible Binding Sites On Rna
  • Antisense Modulation Of Sr-Cyp Expression
  • Antisense Modulation Of Ptp1b Expression
  • Modulation Of Hematopoietic Cell; Controlling Cell Differentiation, Cell Proliferation
  • Estrogen Receptor Site-Specific Ribozymes And Uses Thereof For Estrogen Dependent Tumors
  • Modulation Of Signal Transducer And Activator Of Transcription 3 (Stat3) Expression
  • P53 Antisense Agent And Method
  • Antisense Oligonucleotides Targeted To Superoxide Dismutase 1(Sod1) , For Use In Inhibiting The Expression Of Sod1 In The Central Nervous System Of An Individual For Slowing Amyotrophic Lateral Sclerosis; Oligonucleotide With Modified Sugar Base, Phosphorothioate Linkage, 5-Methylcytosine Nucleobase
  • Antisense Modulation Of Ptp1b Expression
  • Oligonucleotide Of Given Dna Sequence Which Specifically Hybridizes With One Of Said Regions And Inhibits The Expression Of The Enzyme; Can Use In Treating Diabetes And Cancer
  • Trpm-2 Antisense Therapy
  • Antisense Modulation Of Superoxide Dismutase 1, Soluble Expression
  • Chemo- And Radiation-Sensitization Of Cancer By Antisense Trpm-2 Oligodeoxynucleotides
  • Chemo- And Radiation-Sensitization Of Cancer By Antisense Trpm-2 Oligodeoxynucleotides
  • Modulation Of Signal Transducer And Activator Of Transcription 3 (Stat3) Expression
  • Rna Interference Mediated Inhibition Of Gene Expression Using Short Interfering Nucleic Acids (Sina)
  • Antisense Modulation Of Connective Tissue Growth Factor Expression
  • Conjugates And Compositions For Cellular Delivery
  • Antisense Inhibition Of Ets-2 Expression
  • Methods For Analyzing Nucleic Acid
  • Rna Interference Mediated Inhibition Of Gene Expression Using Short Interfering Nucleic Acids (Sina)
  • Antisense Modulation Of Sphingosine-1-Phosphate Lyase Expression
  • Enzymatic Polypeptide For Use In The Diagnosis And Treatment Of Cancer
  • Conjugates And Compositions For Cellular Delivery
  • Compositions For Modulating Sod-1 Expression
  • Antisense Inhibition Of Nucleolin Expression
  • An Antisense Nucleotide; Therapy For Metabolic Diseases, Diabetes
  • Detection Of Nucleic Acid Sequence Differences Using The Ligase Detection Reaction With Addressable Arrays
  • Administering Antisense Oligonucleotides Complementary To Human Apolipoprotein B
  • Inhibitors Of Tgf-R Signaling For Treatment Of Cns Disorders
  • Antisense Modulation Of Apolipoprotein B Expression
  • Antisense Modulation Of Lar Expression
  • Sap-1 (Serum-Response Factor Accessory Protein-1); Oligonucleotides Targeted To Nucleic Acids Encoding Sap-1; Use In Treatment Of Cancer; Anti-Cancer Agents
  • Treatment Of Cancer By Inhibition Of Igfbps And Clusterin
  • Antisense Modulation Of Ptp1b Expression
  • Antisense Treatments For Melanoma By Inhibition Of Clusterin, Also Known As Testosterone-Repressed Prostate Message-2, For Example By Administration Of Antisense Oligonucleotides Specific For Clusterin
  • An Oligonucleotide That Encodes A Human Protein Kinases Involved In Signal Transduction Regulating Cell Proliferation; Anticarcinogenic/Antitumor Agents, Diagnosis And Therapy Of Psoriasis, Artherosclerosis, Tissue Grafts
  • Detection Of Nucleic Acid Sequence Differences Using Coupled Ligase Detection And Polymerase Chain Reactions
  • Detection Of Nucleic Acid Sequence Differences Using The Ligase Detection Reaction With Addressable Arrays
  • Methods For Inhibiting Expression Of Connective Tissue Growth Factor
  • Antisense Modulation Of Ptp1b Expression
  • Using Primer Mismatches To Identify And Amplify Polymorphic Target Gene Sequences; Mutational Analysis; Multiplex Detection Of Nucleic Acid Sequence Differences
  • Antisense Modulation Of Apolipoprotein B-Expression
  • Method Of Designing Addressable Array Suitable For Detection Of Nucleic Acid Sequence Differences Using Ligase Detection Reaction
  • Rna Interference Mediated Inhibition Of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (Sina)
  • Antisense Modulation Of Stearoyl-Coa Desaturase Expression
  • Using Primer Mismatches To Identify And Amplify Polymorphic Target Gene Sequences; Mutational Analysis; Multiplex Detection Of Nucleic Acid Sequence Differences
  • Antisense Modulation Of Chk2 Expression
  • Rna Interference Mediated Inhibition Of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (Sina)
  • Antisense Modulation Of Lar Expression
  • Rna Interference Mediated Inhibition Of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (Sina)
  • Antisense Modulation Of Ptp1b Expression
  • Detection Of Nucleic Acid Sequence Differences Using The Ligase Detection Reaction With Addressable Arrays
  • Modulation Of Fetoprotein Transcription Factor Expression
  • Antisense Modulation Of Integrin Beta 4 Binding Protein Expression
  • Antisense Modulation Of Sr-Cyp Expression
  • Compounds And Methods For Modulating Expression Apob
  • Oligonucleotides Which Hybridize Nucleic Acids Which Encode Said Enzymes; Gene Therapy; Genetic Engineering; For Treatment Of Abnormal Lipid Metabolism, Athersclerosis, And Cardiovascular Disease
  • Forming A Ligation Product On A Target Nucleotide Sequence; Amplifying The Product; Detecting The Amplified Product, And Identifying The Target Nucleotide Sequence; Multiplex Methods
  • Compositions For Modulating Sod-1 Expression
  • Antisense Inhibition Of Hpk/Gck-Like Kinase Expression
  • Chemically Modified Multifunctional Short Interfering Nucleic Acid Molecules That Mediate Rna Interference
  • Gene Expression Inhibition; Treating Developmental Disorders Or Aberrant Apoptosis
  • Clusterin Antisense Therapy For Treatment Of Cancer
  • Gene Expression Inhibition; Antiproliferative, Anticancer And Antiarthritic Agents; Angiogenesis Inhibitors
  • Rna Interference Mediated Inhibition Of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (Sina)
  • For Environmental/Forensic/Food/Feed Monitoring; Kits, Solid Phase Synthesis
  • Inhibition Of Bcl-2 Protein Expression By Liposomal Antisense Oligodeoxynucleotides
  • Method For Identifying Accessible Binding Sites On Rna
  • Rna Interference Mediated Inhibition Of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (Sina)
  • Antisense Modulation Of Fra-1 Expression
  • Nucleotide Sequences; Oligonucleotides
  • Hybrid Nucleic Acids; Controlling Gene Expression
  • Detection Of Nucleic Acid Sequence Differences Using The Ligase Detection Reaction With Addressable Arrays
  • Antisense Modulation Of Stearoyl-Coa Desaturase Expression
  • Method Of Designing Addressable Array Suitable For Detection Of Nucleic Acid Sequence Differences Using Ligase Detection Reaction
  • Antisense Modulation Of Cd40 Expression
  • Polymorphism Analysis By Nucleic Acid Structure Probing
  • Detection Of Nucleic Acid Sequence Differences Using The Ligase Detection Reaction With Addressable Arrays
  • Method Of Designing Addressable Array Suitable For Detection Of Nucleic Acid Sequence Differences Using Ligase Detection Reaction
  • Method For Reducing Scarring During Wound Healing Using Antisense Compounds Directed To Ctgf
  • Detecting Nucleic Acids In Samples By Binding A Fluorescently Labeled Nucleic Acid Probe, Having A Hairpin Structure, To A Solid Phase; Solid Phase Quenches The Label If The Hairpin Structure Exists; Analyzing Nucleic Acid Sequences
  • Method Of Designing Addressable Array For Detection Of Nucleic Acid Sequence Differences Using Ligase Detection Reaction
  • Antisense Modulation Of Cd40 Expression
  • Rna Interference Mediated Inhibition Of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (Sina)
  • Reduces The Expression Of Testosterone-Repressed Prostate Message-2 Provides Therapeutic Benefits In The Treatment Of Cancer For Example Prostate Cancer And Renal Cell Cancer; Combined Use With Taxanes Synergistically Enhances Cytotoxic Chemosensitivity Of Androgen-Independent Prostate Cancer
  • Modified Protein Kinase A-Specific Oligonucleotides And Methods Of Their Use
  • Antisense Modulation Of Superoxide Dismutase 1, Soluble Expression
  • Analyzing Nucleotide Sequences And Detecting Sequence Adjustments; Mixing Preferential Nucleotide Sequences And Conformation Activating Sequences, Recover Cleavage Products
  • Method Of Designing Addressable Array Suitable For Detection Of Nucleic Acid Sequence Differences Using Ligase Detection Reaction
  • Detection Of Nucleic Acid Sequence Differences Using The Ligase Detection Reaction With Addressable Arrays
  • Treatment Of Cancer By Inhibition Of Igfbps And Clusterin
  • Comprises Oligonucleotide Probes For Hybridization; Medical Diagnosis
  • Detection Of Nucleic Acid Sequence Differences Using Coupled Ligase Detection And Polymerase Chain Reactions
  • Antisense Oligonucleotide Modulation Of Stat3 Expression
  • Nucleotide Sequences That Prevent The Expression Of A Human Polypeptide That Prevent Apoptosis In Tumor Cells; Anticarcinogenic Agents
  • Treatment Of Cancer By Inhibition Of Igfbps And Clusterin
  • Antisense Modulation Of Ptp1b Expression
  • Rna Interference Mediated Inhibition Of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (Sina)
  • Antisense Modulation Of Glioma-Associated Oncogene-3 Expression
  • Antisense Oligonucleotides Directed Against Connective Tissue Growth Factor And Uses Thereof
  • Methods And Compositions For Diagnosis And Treatment Of Pathological Conditions Related To Abnormal Dopamine Receptor Expression
  • Oligonucleoside Compounds And Methods For Inhibiting Tumor Growth, Invasion And Metastasis
  • Detecting The Presence Of A Target Nucleic Acid Molecule By Detecting Non-Target Cleavage Products
  • Trpm-2 Antisense Therapy
  • Treatment Of Cancer By Inhibition Of Igfbp's And Clusterin
  • Antisense Modulation Of Il-1 Receptor-Associated Kinase-4 Expression
  • Stress-Phosphorylated Endoplasmic Reticulum Protein, Nogo B, For Therapy
  • Methods For Placing, Accepting, And Filling Orders For Products And Services
  • Antisense Modulation Of Survivin Expression
  • Compositions For Modulating Sod-1 Expression
  • Nucleotide Sequences For Use As Tool In Controlling Protein Tyrosine Phosphatase-1b Gene Expression And Treatment Of Diabetes; Gene Expression Inhibition
  • Detection Of Nucleic Acid Sequence Differences Using The Ligase Detection Reaction With Addressable Arrays
  • Rna Interference Mediated Inhibition Of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (Sina)
  • Administration Of A Chemotherapeutic Agent And A Formulation Containing A Cationic Liposomes Which Consists Of Cationic Lipid, Phosphatidylcholine And Cholesterol And Having Encapsulated Therein An Oligonucleotide
  • Antisense Modulation Of Ptp1b Expression
  • Detection Of Nucleic Acid Sequence Differences Using The Ligase Detection Reaction With Addressable Arrays
  • Snps Of Apolipoprotein B And Modulation Of Their Expression
  • Antisense Oligonucleotides Directed Against Connective Tissue Growth Factor And Uses Thereof
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/nbt0697-537

    DOI

    http://dx.doi.org/10.1038/nbt0697-537

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1022203075

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/9181575


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Biological Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0604", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Genetics", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Base Sequence", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Exons", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Globins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Molecular Sequence Data", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Nucleic Acid Conformation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Nucleic Acid Heteroduplexes", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Oligodeoxyribonucleotides", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "RNA, Messenger", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Rabbits", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Transcription, Genetic", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Biochemistry, University of Oxford, South Parks Road, OX1 3QU, Oxford, UK", 
              "id": "http://www.grid.ac/institutes/grid.4991.5", 
              "name": [
                "Department of Biochemistry, University of Oxford, South Parks Road, OX1 3QU, Oxford, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Milner", 
            "givenName": "Natalie", 
            "id": "sg:person.01247714071.41", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01247714071.41"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Biochemistry, University of Oxford, South Parks Road, OX1 3QU, Oxford, UK", 
              "id": "http://www.grid.ac/institutes/grid.4991.5", 
              "name": [
                "Department of Biochemistry, University of Oxford, South Parks Road, OX1 3QU, Oxford, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Mir", 
            "givenName": "Kalim U.", 
            "id": "sg:person.01320751674.99", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01320751674.99"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Biochemistry, University of Oxford, South Parks Road, OX1 3QU, Oxford, UK", 
              "id": "http://www.grid.ac/institutes/grid.4991.5", 
              "name": [
                "Department of Biochemistry, University of Oxford, South Parks Road, OX1 3QU, Oxford, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Southern", 
            "givenName": "Edwin M.", 
            "id": "sg:person.01050717725.08", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050717725.08"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/nm0696-668", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1039646445", 
              "https://doi.org/10.1038/nm0696-668"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt0796-840", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001313757", 
              "https://doi.org/10.1038/nbt0796-840"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "1997-06", 
        "datePublishedReg": "1997-06-01", 
        "description": "An array of 1,938 oligodeoxynucleotides (ONs) ranging in length from monomers to 17-mers was fabricated on the surface of a glass plate and used to measure the potential of oligonucleotide for heteroduplex formation with rabbit \u03b2-globin mRNA. The oligonucleotides were complementary to the first 122 bases of mRNA comprising the 5\u2032 UTR and bases 1 to 69 of the first exon. Surprisingly few oligonucleotides gave significant heteroduplex yield. Antisense activity, measured in a RNase H assay and by in vitro translation, correlated well with yield of heteroduplex on the array. These results help to explain the variable success that is commonly experienced in the choice of antisense oligonucleotides. For the optimal ON, the concentration required to inhibit translation by 50% was found to be five times less than for any other ON. We find no obvious features in the mRNA sequence or the predicted secondary structure that can explain the variation in heteroduplex yield. However, the arrays provide a simple empirical method of selecting effective antisense oligonucleotides for any RNA target of known sequence.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/nbt0697-537", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1115214", 
            "issn": [
              "1087-0156", 
              "1546-1696"
            ], 
            "name": "Nature Biotechnology", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "6", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "15"
          }
        ], 
        "keywords": [
          "RNase H assays", 
          "antisense activity", 
          "effective antisense", 
          "antisense reagents", 
          "effective antisense reagents", 
          "rabbit \u03b2-globin mRNA", 
          "array", 
          "oligonucleotide", 
          "basis of mRNA", 
          "antisense", 
          "glass plate", 
          "RNA targets", 
          "h assay", 
          "heteroduplex formation", 
          "yield", 
          "oligonucleotide arrays", 
          "oligodeoxynucleotides", 
          "surface", 
          "mRNA sequences", 
          "vitro translation", 
          "heteroduplexes", 
          "assays", 
          "reagents", 
          "potential", 
          "structure", 
          "secondary structure", 
          "method", 
          "sequence", 
          "formation", 
          "concentration", 
          "monomers", 
          "translation", 
          "first exon", 
          "length", 
          "obvious features", 
          "time", 
          "activity", 
          "exons", 
          "results", 
          "simple empirical method", 
          "plate", 
          "features", 
          "\u03b2-globin mRNA", 
          "target", 
          "choice", 
          "mRNA", 
          "success", 
          "variation", 
          "basis", 
          "variable success", 
          "UTR", 
          "bases 1", 
          "empirical methods"
        ], 
        "name": "Selecting effective antisense reagents on combinatorial oligonucleotide arrays", 
        "pagination": "537-541", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1022203075"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/nbt0697-537"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "9181575"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/nbt0697-537", 
          "https://app.dimensions.ai/details/publication/pub.1022203075"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-11-24T20:47", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_289.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/nbt0697-537"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/nbt0697-537'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/nbt0697-537'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/nbt0697-537'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/nbt0697-537'


     

    This table displays all metadata directly associated to this object as RDF triples.

    180 TRIPLES      21 PREDICATES      92 URIs      82 LITERALS      18 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/nbt0697-537 schema:about N08b4e3ee1d524487941bce5407c90f51
    2 N3487c94c7ca6401694550fafbd402d0e
    3 N3ca16fc220594174988b9676fc54f8b8
    4 N501d77e0abf642b2b962c0b6b9850d3b
    5 N65b127dfb30643c8b267fb9f3893d647
    6 N714b04468ea5421eb305e2d90a054ef5
    7 N9907707c73fa4c4f9d476f13264f808a
    8 Na107aae959ee4eacbcea5c7764e67a61
    9 Nc40085c5ac2b4b73bbf857b0da3b25c4
    10 Ne3e4346e7a744046ac679650f68a7015
    11 Nf99eafc90cc044189a78259c89dd1af3
    12 anzsrc-for:06
    13 anzsrc-for:0604
    14 schema:author Nd8ae9e45b9e14a5db24c3d19352023aa
    15 schema:citation sg:pub.10.1038/nbt0796-840
    16 sg:pub.10.1038/nm0696-668
    17 schema:datePublished 1997-06
    18 schema:datePublishedReg 1997-06-01
    19 schema:description An array of 1,938 oligodeoxynucleotides (ONs) ranging in length from monomers to 17-mers was fabricated on the surface of a glass plate and used to measure the potential of oligonucleotide for heteroduplex formation with rabbit β-globin mRNA. The oligonucleotides were complementary to the first 122 bases of mRNA comprising the 5′ UTR and bases 1 to 69 of the first exon. Surprisingly few oligonucleotides gave significant heteroduplex yield. Antisense activity, measured in a RNase H assay and by in vitro translation, correlated well with yield of heteroduplex on the array. These results help to explain the variable success that is commonly experienced in the choice of antisense oligonucleotides. For the optimal ON, the concentration required to inhibit translation by 50% was found to be five times less than for any other ON. We find no obvious features in the mRNA sequence or the predicted secondary structure that can explain the variation in heteroduplex yield. However, the arrays provide a simple empirical method of selecting effective antisense oligonucleotides for any RNA target of known sequence.
    20 schema:genre article
    21 schema:isAccessibleForFree false
    22 schema:isPartOf Na7f7639576344e46bc6a1ca29f3dce4d
    23 Naf0fce103ca24b43964ff2f6ca9aaef3
    24 sg:journal.1115214
    25 schema:keywords RNA targets
    26 RNase H assays
    27 UTR
    28 activity
    29 antisense
    30 antisense activity
    31 antisense reagents
    32 array
    33 assays
    34 bases 1
    35 basis
    36 basis of mRNA
    37 choice
    38 concentration
    39 effective antisense
    40 effective antisense reagents
    41 empirical methods
    42 exons
    43 features
    44 first exon
    45 formation
    46 glass plate
    47 h assay
    48 heteroduplex formation
    49 heteroduplexes
    50 length
    51 mRNA
    52 mRNA sequences
    53 method
    54 monomers
    55 obvious features
    56 oligodeoxynucleotides
    57 oligonucleotide
    58 oligonucleotide arrays
    59 plate
    60 potential
    61 rabbit β-globin mRNA
    62 reagents
    63 results
    64 secondary structure
    65 sequence
    66 simple empirical method
    67 structure
    68 success
    69 surface
    70 target
    71 time
    72 translation
    73 variable success
    74 variation
    75 vitro translation
    76 yield
    77 β-globin mRNA
    78 schema:name Selecting effective antisense reagents on combinatorial oligonucleotide arrays
    79 schema:pagination 537-541
    80 schema:productId N59b443fc78a84b4b8c0d4edc9df6f852
    81 Nc336e1e4ca5b46759a7979637ffe5aff
    82 Nf6eb4667fc554a23908bdb8c5b8c2fc6
    83 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022203075
    84 https://doi.org/10.1038/nbt0697-537
    85 schema:sdDatePublished 2022-11-24T20:47
    86 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    87 schema:sdPublisher N1ed7b2a21e5845f2aaa9173aa96c209a
    88 schema:url https://doi.org/10.1038/nbt0697-537
    89 sgo:license sg:explorer/license/
    90 sgo:sdDataset articles
    91 rdf:type schema:ScholarlyArticle
    92 N08b4e3ee1d524487941bce5407c90f51 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    93 schema:name RNA, Messenger
    94 rdf:type schema:DefinedTerm
    95 N1ed7b2a21e5845f2aaa9173aa96c209a schema:name Springer Nature - SN SciGraph project
    96 rdf:type schema:Organization
    97 N3487c94c7ca6401694550fafbd402d0e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    98 schema:name Transcription, Genetic
    99 rdf:type schema:DefinedTerm
    100 N3ca16fc220594174988b9676fc54f8b8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    101 schema:name Rabbits
    102 rdf:type schema:DefinedTerm
    103 N501d77e0abf642b2b962c0b6b9850d3b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    104 schema:name Base Sequence
    105 rdf:type schema:DefinedTerm
    106 N54fb95ce17ba494db2aa6ae13dc2248e rdf:first sg:person.01320751674.99
    107 rdf:rest N96c9231ab1fd4891bbe58ee54d3bcfaa
    108 N59b443fc78a84b4b8c0d4edc9df6f852 schema:name pubmed_id
    109 schema:value 9181575
    110 rdf:type schema:PropertyValue
    111 N65b127dfb30643c8b267fb9f3893d647 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    112 schema:name Animals
    113 rdf:type schema:DefinedTerm
    114 N714b04468ea5421eb305e2d90a054ef5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    115 schema:name Exons
    116 rdf:type schema:DefinedTerm
    117 N96c9231ab1fd4891bbe58ee54d3bcfaa rdf:first sg:person.01050717725.08
    118 rdf:rest rdf:nil
    119 N9907707c73fa4c4f9d476f13264f808a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    120 schema:name Nucleic Acid Conformation
    121 rdf:type schema:DefinedTerm
    122 Na107aae959ee4eacbcea5c7764e67a61 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    123 schema:name Nucleic Acid Heteroduplexes
    124 rdf:type schema:DefinedTerm
    125 Na7f7639576344e46bc6a1ca29f3dce4d schema:volumeNumber 15
    126 rdf:type schema:PublicationVolume
    127 Naf0fce103ca24b43964ff2f6ca9aaef3 schema:issueNumber 6
    128 rdf:type schema:PublicationIssue
    129 Nc336e1e4ca5b46759a7979637ffe5aff schema:name doi
    130 schema:value 10.1038/nbt0697-537
    131 rdf:type schema:PropertyValue
    132 Nc40085c5ac2b4b73bbf857b0da3b25c4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    133 schema:name Oligodeoxyribonucleotides
    134 rdf:type schema:DefinedTerm
    135 Nd8ae9e45b9e14a5db24c3d19352023aa rdf:first sg:person.01247714071.41
    136 rdf:rest N54fb95ce17ba494db2aa6ae13dc2248e
    137 Ne3e4346e7a744046ac679650f68a7015 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    138 schema:name Molecular Sequence Data
    139 rdf:type schema:DefinedTerm
    140 Nf6eb4667fc554a23908bdb8c5b8c2fc6 schema:name dimensions_id
    141 schema:value pub.1022203075
    142 rdf:type schema:PropertyValue
    143 Nf99eafc90cc044189a78259c89dd1af3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    144 schema:name Globins
    145 rdf:type schema:DefinedTerm
    146 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
    147 schema:name Biological Sciences
    148 rdf:type schema:DefinedTerm
    149 anzsrc-for:0604 schema:inDefinedTermSet anzsrc-for:
    150 schema:name Genetics
    151 rdf:type schema:DefinedTerm
    152 sg:journal.1115214 schema:issn 1087-0156
    153 1546-1696
    154 schema:name Nature Biotechnology
    155 schema:publisher Springer Nature
    156 rdf:type schema:Periodical
    157 sg:person.01050717725.08 schema:affiliation grid-institutes:grid.4991.5
    158 schema:familyName Southern
    159 schema:givenName Edwin M.
    160 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050717725.08
    161 rdf:type schema:Person
    162 sg:person.01247714071.41 schema:affiliation grid-institutes:grid.4991.5
    163 schema:familyName Milner
    164 schema:givenName Natalie
    165 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01247714071.41
    166 rdf:type schema:Person
    167 sg:person.01320751674.99 schema:affiliation grid-institutes:grid.4991.5
    168 schema:familyName Mir
    169 schema:givenName Kalim U.
    170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01320751674.99
    171 rdf:type schema:Person
    172 sg:pub.10.1038/nbt0796-840 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001313757
    173 https://doi.org/10.1038/nbt0796-840
    174 rdf:type schema:CreativeWork
    175 sg:pub.10.1038/nm0696-668 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039646445
    176 https://doi.org/10.1038/nm0696-668
    177 rdf:type schema:CreativeWork
    178 grid-institutes:grid.4991.5 schema:alternateName Department of Biochemistry, University of Oxford, South Parks Road, OX1 3QU, Oxford, UK
    179 schema:name Department of Biochemistry, University of Oxford, South Parks Road, OX1 3QU, Oxford, UK
    180 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...